| Role of cell shape in growth control J Folkman, A Moscona Nature 273 (5661), 345-349, 1978 | 3151 | 1978 |
| Neuraminidase inhibitors for influenza A Moscona New England Journal of Medicine 353 (13), 1363-1373, 2005 | 1530 | 2005 |
| Global transmission of oseltamivir-resistant influenza A Moscona New England Journal of Medicine 360 (10), 953-956, 2009 | 594 | 2009 |
| A three-dimensional model of human lung development and disease from pluripotent stem cells YW Chen, SX Huang, ALRT De Carvalho, SH Ho, MN Islam, S Volpi, ... Nature cell biology 19 (5), 542-549, 2017 | 557 | 2017 |
| Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum SP Weisberg, TJ Connors, Y Zhu, MR Baldwin, WH Lin, S Wontakal, ... Nature immunology 22 (1), 25-31, 2021 | 527 | 2021 |
| Oseltamivir resistance—disabling our influenza defenses A Moscona New England Journal of Medicine 353 (25), 2633-2636, 2005 | 525 | 2005 |
| Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1 JD Parvin, A Moscona, WT Pan, JM Leider, P Palese Journal of virology 59 (2), 377-383, 1986 | 379 | 1986 |
| A broad-spectrum antiviral targeting entry of enveloped viruses MC Wolf, AN Freiberg, T Zhang, Z Akyol-Ataman, A Grock, PW Hong, J Li, ... Proceedings of the National Academy of Sciences 107 (7), 3157-3162, 2010 | 301 | 2010 |
| The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2 JP Parisien, JF Lau, JJ Rodriguez, BM Sullivan, A Moscona, GD Parks, ... Virology 283 (2), 230-239, 2001 | 270 | 2001 |
| In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age NAP Lieberman, V Peddu, H Xie, L Shrestha, ML Huang, MC Mears, ... PLoS biology 18 (9), e3000849, 2020 | 260 | 2020 |
| Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets RD de Vries, KS Schmitz, FT Bovier, C Predella, J Khao, D Noack, ... Science 371 (6536), 1379-1382, 2021 | 203 | 2021 |
| Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease A Moscona The Journal of clinical investigation 115 (7), 1688-1698, 2005 | 180 | 2005 |
| Medical management of influenza infection A Moscona Annu. Rev. Med. 59 (1), 397-413, 2008 | 170 | 2008 |
| Immunization of pediatric solid organ transplant candidates and recipients M Burroughs, A Moscona Clinical infectious diseases 30 (6), 857-869, 2000 | 157 | 2000 |
| Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry M Porotto, B Rockx, CC Yokoyama, A Talekar, I DeVito, LM Palermo, J Liu, ... PLoS pathogens 6 (10), e1001168, 2010 | 144 | 2010 |
| Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids M Porotto, M Ferren, YW Chen, Y Siu, N Makhsous, B Rima, T Briese, ... MBio 10 (3), 10.1128/mbio. 00723-19, 2019 | 135 | 2019 |
| Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion A Moscona, RW Peluso Journal of virology 65 (6), 2773-2777, 1991 | 132 | 1991 |
| Viral entry inhibitors targeted to the membrane site of action M Porotto, CC Yokoyama, LM Palermo, B Mungall, M Aljofan, R Cortese, ... Journal of virology 84 (13), 6760-6768, 2010 | 113 | 2010 |
| A Second Receptor Binding Site on Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Contributes to Activation of the FusionMechanism M Porotto, M Fornabaio, GE Kellogg, A Moscona Journal of virology 81 (7), 3216-3228, 2007 | 113 | 2007 |
| Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion M Porotto, M Murrell, O Greengard, A Moscona Journal of virology 77 (6), 3647-3654, 2003 | 113 | 2003 |
Eric JurgensWeill Cornell Medical CollegeVerified email at cornell.edu
